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Endoplasmic reticulum (ER) stress and activation of the unfolded protein response have been linked to
many human disorders, including obesity, type 2 diabetes, and cancer. In this issue of Developmental
Cell,Rutkowski et al. (2008) show that unresolved ER stress contributes tometabolic dysfunction and hepatic
steatosis.Correct processing and maturation of se-
cretory, transmembrane, and endoplas-
mic reticulum (ER)-resident proteins is
dependent on the folding capacity of the
ER, where nascent polypeptide chains
fold into their native conformation (Lee,
2001). To prevent protein aggregates
and enhance protein folding, the ER
lumen contains a high concentration of
ER chaperones and foldases such as
GRP78, PDI, and calnexin. If ER homeo-
stasis is disrupted, an adaptive mecha-
nism known as the unfolded protein
response (UPR) is activated to allow the
cell to cope with pathophysiological
agents/conditions known to elicit ER
stress. The UPR is comprised of three
integrated pathways that are activated
through the ER transmembrane proteins
PERK, IRE1a and ATF6. Activation of
these pathways has cytoprotective ef-
fects and allows for cell survival under
moderate ER stress conditions. However,
prolonged or severe ER stress can lead to
proapoptotic signals such as CHOP upre-
gulation that interfere with normal cellular
functions. In this issue of Developmental
Cell, Rutkowski et al. (2008) examined
the contribution of each of the UPR path-
ways to the regulation of metabolic genes
in the liver and their effect on the develop-
ment of hepatic dyslipidemia and steato-
sis. In addition to these findings, several
recent studies have also provided impor-
tant clues involving the role of UPR activa-
tion on lipid homeostasis in the liver.
Previous studies have demonstrated
that ER stress can activate the sterol
regulatory element-binding proteins
(SREBPs), transcription factors involved
in de novo lipid biosynthesis (Colgan
et al., 2007; Lee and Ye, 2004). TheSREBPs play an important role in choles-
terol metabolism and LDL receptor ex-
pression (SREBP-2) as well as fatty acid
and triglyceride biosynthesis (SREBP-1)
(Goldstein et al., 2006; Horton, 2002).
Insulin is known to activate SREBP-1c in
the liver, leading to the upregulation of
genes such as fatty acid synthase and
acetyl-coenzyme A carboxylase. Expres-
sion of lipogenic enzymes and transcrip-
tion factors can affect hepatic triglyceride
production and secretion, as well as the
development of hepatic steatosis. Condi-
tions such as hyperhomocysteinemia and
high alcohol consumption can lead to he-
patic steatosis and have been linked to
ER stress-induced SREBP-1c activation
(Ferre and Foufelle, 2007; Werstuck
et al., 2001). However, this is not the com-
plete story involving ER stress, UPR acti-
vation, and hepatic steatosis.
Rutkowski et al. (2008) investigated the
function of each arm of the UPR on he-
patic metabolic dysfunction in vivo using
transgenic mouse models deficient in
specific genes encoding ER stress sens-
ing pathways. A recent report showed
that the transcription factor XBP-1, which
is directly activated by the IRE1a path-
way, regulates hepatic lipogenesis with-
out affecting hepatic protein secretory
function (Lee et al., 2008). Lee and col-
leagues examined the function of XBP-1
through inducible and conditional disrup-
tion of Xbp-1 in the livers of mice. They
observed a profound decrease in serum
triglycerides, cholesterol, and free fatty
acids in mice deficient in XBP-1. This
was accompanied by decreased de novo
lipogenesis in the liver. Interestingly, the
role of XBP-1 in hepatic lipid regulation
was independent of its role as an ERDevelopmental Cell 15,stress-response mediator. These findings
suggest that XBP-1, at least in the liver,
can function as a metabolic regulator of
genes involved in lipid metabolism. In ad-
dition, a recent study by Oyadomari et al.
(2008) showed that the PERK-eIF2a arm
of the UPR pathway can directly regulate
intermediary metabolism, thereby leading
to enhanced glucose tolerance and
diminished hepatic steatosis in high-fat-
diet fed mice. This analysis provided
further in vivo evidence that nutritional
fluctuations and nutrient excess can lead
to phosphorylation of eIF2a and the
integrated stress response. Importantly,
disruption of the integrated stress re-
sponse in the liver may serve to protect
against the deleterious effects of nutrient
excess on the metabolic phenotype by
decreasing expression of C/EBPa and
PPARg and their target lipogenic en-
zymes. Whether these recent findings
are directly linked to ER stress in the
hepatocyte is not fully known.
To investigate the effect of acute ER
stress on lipogenesis and hepatic steato-
sis, Rutkowski et al. (2008) treated mice
with tunicamycin, an inhibitor of N-linked
glycosylation. They studied the effect of
the tunicamycin challenge on the livers
of four mouse models: (1) mice nullizy-
gous for the Atf6a gene, (2) mice with
liver-specific deletion of Ire1a, (3) mice
with a liver-specific dominant-negative
eIF2a, and (4) mice nullizygous for p58,
a GRP78 cochaperone. In Atf6/, liver-
specific Ire1a/ as well as p58/ mice,
tunicamycin treatment led to a chronic
upregulation and nuclear localization of
CHOP, indicating prolonged ER stress,
while wild-type mice showed only a tran-
sient upregulation. CHOP, a C/EBPDecember 9, 2008 ª2008 Elsevier Inc. 795
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Previewshomologous protein, can in-
terfere with the function of
C/EBPa, a transcription factor
involved in hepatic gluconeo-
genesis and lipid homeosta-
sis. C/EBPa gene expression
was reduced by tunicamycin
in mice with defective UPR
signaling (Rutkowski et al.,
2008). This finding paralleled
the observation by Oyadomari
and colleagues indicating that
hepatic C/EBPaandbexpres-
sion were reduced in mice de-
fective in eIF2a phosphoryla-
tion (Oyadomari et al., 2008).
Thus, decreased C/EBPa in
combination with high CHOP
expression levels and de-
creased fatty acid oxidation
disrupts hepatic lipid metabo-
lism and results in fatty liver.
While phosphorylation of
eIF2a can lead to glucose in-
tolerance and hepatic steato-
sis (Oyadomari et al., 2008),
the findings by Rutkowski
et al. (2008) demonstrate that
defective eIF2a phosphoryla-
tion during acute ER stress
results in hepatic lipid accu-
mulation. Since the livers of tu-
nicamycin-challenged mice experienced
prolonged and unresolved ER stress, de-
fective UPR signaling can be detrimental
to cellular function, leading to a disruption
if hepatic lipid homeostasis (see Figure 1).
Although Lee et al. (2008) did not observe
hepatic steatosis in the liver-specific Xbp-
1-deficient mice, tunicamycin treatment
of liver-specific Ire1a/ mice in the Rut-
kowski et al. (2008) study increased he-
patic lipid accumulation. These findings
suggest differential regulation of lipogenic
genes during unresolved ER stress as
compared to physiological ER stress
caused by dietary challenges such as
high-carbohydrate or high-fat diets.
The question that still remains is whether
hepatic lipid accumulation and a decrease
in fatty acid oxidation have any protective
functions in hepatocytes exposed to acute
ER stress. Deposition and storage of lipids
in tissues such as white adipose tissue is
thought to prevent dyslipidemia and
ectopic fat accumulation. So, it remains
to be elucidated whether the hepatic stea-
tosis associated with severe forms of ER
stress is an adaptive response to adverse
physiological conditions. Perhaps accu-
mulation of lipids in the liver
under ER stress conditions
prevents the secretion of
triglycerides and free fatty
acids into the circulation. If
so, this may represent a fine
balance between hepatic
lipid storage and secretion un-
der pathophysiological condi-
tions that induce ER stress.
As a result, these studies pro-
vide some solid footing on the
slippery slope toward under-
standing the development
and progression of hepatic
steatosis.
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Figure 1. Model Illustrating How Prolonged and Unresolved ER
Stress in the Liver Disrupts Lipid Homeostasis and Results in the
Development of Hepatic Steatosis
Under conditions of physiological ER stress, hepatocytes respond by activat-
ing the UPR. The subsequent increase in the expression of ER chaperones and
phosphorylation of eIF2a relieves the hepatocyte of the stress (left). However,
if hepatic UPR signaling is defective (right), prolonged CHOP expression and/
or phosphorylation of eIF2a can result in increased expression of lipogenic
genes as well as decreased expression of genes required for fatty acid oxida-
tion. These metabolic changes induced by ER stress lead to the development
of hepatic steatosis.796 Developmental Cell 15, December 9, 2008 ª2008 Elsevier Inc.
